Eastman Kodak signs U.S. deal for drug ingredients, says White House's Navarro
July 28 (Reuters) - Eastman Kodak Co
The company's shares were trading at $9.00 after closing at $2.62 on Monday.
The Wall Street journal reported Kodak has been awarded a $765 million government loan under the Defense Production Act, to help speed up domestic production of drugs that can treat different medical conditions and lower reliance on foreign sources. (https://on.wsj.com/2Da0b9p)
Eastman Kodak did not immediately respond to a Reuters request for comment. (Reporting by Dania Nadeem in Bengaluru; Editing by Shounak Dasgupta) ((Dania.Nadeem@thomsonreuters.com; within U.S. +1 646 223 8780, outside U.S. +91 80 6182 3463)) Keywords: EASTMAN KODAK DEALS/ (URGENT)
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.